Chinese regulators are investigating the quality of domestic generic drugs after a rare public backlash against a cost-cutting campaign that prioritised their use in the national healthcare system but ...

Despite having a couple good ideas, Kennedy's background and health platform as a whole should disqualify him. He is the ...